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Abstract
Background: Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously been shown
to be affected by variants at three loci on chromosomes 2, 6 and 11, but it is likely that additional loci remain to be
discovered.
Methods and Findings: We conducted a genome-wide association study (GWAS) in 1,213 SCA (HbSS/HbSb0) patients in
Tanzania. Genotyping was done with Illumina Omni2.5 array and imputation using 1000 Genomes Phase I release data.
Association with HbF was analysed using a linear mixed model to control for complex population structure within our study.
We successfully replicated known associations for HbF near BCL11A and the HBS1L-MYB intergenic polymorphisms (HMIP),
including multiple independent effects near BCL11A, consistent with previous reports. We observed eight additional
associations with P,1026. These associations could not be replicated in a SCA population in the UK.
Conclusions: This is the largest GWAS study in SCA in Africa. We have confirmed known associations and identified new
genetic associations with HbF that require further replication in SCA populations in Africa.
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Introduction
Tanzania has one of the highest number of births of individuals
with sickle cell disease (SCD) in the world, estimated to be between
8,000 and 11,000 births a year [1]. Fetal hemoglobin (HbF) is a
major ameliorating factor in SCD. Patients with higher HbF levels
have less pain [2,3], lower morbidity and improved survival [2,4].
The inter-individual HbF variation has been associated with
variants at three principal loci [5–7]; the region on chromosome
11p that contains the HBB itself [8] and loci on chromosomes 2p
(BCL11A) and 6q (HBS1L-MYB intergenic polymorphism,
HMIP). Rare variants in KLF1 have also been reported to
influence HbF levels [9]. Of the three principal loci influencing
HbF, BCL11A variants have been found to be more prevalent in
the British, American and Brazilian patients of African descent [6–
8,10,11] than HMIP and HBB variants. Similarly, in Tanzania
BCL11A variants (rs11886868 and rs4671393) had the highest
overall impact, with rs4671393 alone accounting for up to 12.8%
HbF variance [12]. Notably, most of the reported BCL11A
variants reside within the intron 2 of the gene [6,8,10,13–16], and
appear to occur in moderate to high linkage disequilibrium (LD) in
African ancestry [15] in Southwest USA (ASW) [17]. This suggests
that African populations may be suitable for the identification and
fine mapping of the causal variant/s for the BCL11A locus.
Together, the 3 loci have been reported to account for up to 50%
of HbF variation in non-anemic individuals in Europe [13].
However, a large proportion of HbF variance in African
populations remains unaccounted for, that justifies the need for
genetic studies of HbF in Africa.
We performed a genome wide association study (GWAS) in
1,213 individuals with SCA in Tanzania to identify new genetic
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loci associated with HbF levels and any additional variants of the
known 3 loci.
Materials and Methods
Study population: Discovery and Replication
1952 samples were collected and genotyped from individuals
who had a diagnosis of SCD. These individuals are part of the
Muhimbili Sickle Cohort recruited at Muhimbili National
Hospital, Dar es Salaam, Tanzania. At Muhimbili, HbF%
measurements are performed by High Performance Liquid
Chromatography (HPLC) (Variant I Hemoglobin Testing System,
Biorad, Hercules, CA) on all individuals with SCA HbF data used
in this study was measured at steady state (defined as malaria test
negative, no reported current pain, fever, blood transfusion or
hospitalization within 30 days (before or after the date of blood
collection). Patients on hydroxyurea and those suspected to be
HbS/b+ were excluded from the study. Figure 1 shows the flow of
samples at different stages of this study. 1742 SCA (HbSS/HbSb0)
individuals had successful genotype data (see quality control
section below) among which 1484 individuals had HbF values
collected. For this study we used HbF data collected at five years of
age and above. Therefore, a total of 1213 individuals with
successful genotype (only HbSS and HbSb0) and HbF data were
included in the discovery cohort. Written informed consent was
obtained from patients/guardians and ethical approval was
obtained from the Muhimbili University Research and publica-
tions committee (MU/RP/AEC/VOL.XIII). The replication
cohort included 321 patients (HbSS and HbS/b0) enrolled
through the Hematology Outpatient Clinic in King’s College
Hospital, London, with written informed consent obtained for all
patients. Ethical approval was granted by the King’s College
Hospital, London, Local Research Ethics Committee, protocol
no 01–083.
Genotyping and replication
DNA was extracted from archived buffy coat samples from
patients collected at enrollment using Nucleon BACC II genomic
DNA extraction kits from GE Healthcare life sciences. Samples
were typed on the Illumina Human Omnichip 2.5 platform
(Illumina Inc., San Diego,CA, USA) which assays ,2.4M Single
Nucleotide Polymorphisms (SNPs). For the replication, 16 SNPs
from 10 loci were selected and assayed using TaqMan (Applied
Biosystems, Foster City, Ca).
Statistical analysis
Quality Control. Standard technical QC was performed
using PLINK to remove potential sources of technical and genetic
bias [18]. A total of 85 samples either found with abnormal
heterozygosity (defined as 3 standard deviation from the mean),
gender mismatch, and those with more than 3% of missing data
were excluded from the study. Following identity-by-descent
analysis, we removed duplicate samples and identified individuals
in first, second, and third-degree relationships. Principal compo-
nents analysis (PCA) was performed using EIGENSTRAT with
1000 Genomes Phase 1 populations as reference groups [19]. We
Figure 1. A flow chart diagram showing the flow of samples at different stages of the study. The genetic quality control measures
involved removal of individuals with abnormal heterozygosity, gender mismatch, missingness of data, removal of duplicate samples and low quality/
rare variants.
doi:10.1371/journal.pone.0111464.g001
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observed population substructure and admixture within the cohort
(Figure 2), and identified 262 individuals showing clear separation
from the core population. Following sample removal, rare and low
quality variants (more than 3% data missing, 1026 Hardy-
Weinberg chi-square P-values, and ,1% MAF) were excluded,
resulting in a typed dataset of 1,827,523 variants in 1,742
individuals.
Imputation was performed using IMPUTE 2.0 with the 1000
Genomes Phase I integrated variant set release as the primary
reference panel [20]. Low quality imputed variants were removed
(,0.4 INFO score and ,1% MAF), with 15,153,765 SNPs and
indels remained for association testing.
HbF association analysis
We carried out our genome-wide association analysis on the
1213 individuals described above. The distribution of HbF levels
was first standardized using three methods: a log transformation, a
power transformation with a lambda of 1/3, and empirical normal
quantile transformation. The transformation methods yielded
consistent results in the later association analyses. In order to take
into account population stratification, genetic and cryptic related-
ness, we used a linear mixed model framework as implemented in
the program MMM [21]. We adjusted for sex and age as fixed
covariates, and allowed for a random effect with variance
dependent on the genetic relatedness between individuals as
determined by a genome-wide panel of SNPs. LD-based clumping
was performed using PLINK to identify independent signals
amongst variants with suggestive significance (P,1025). To
calculate the variance explained by our top loci, we performed
Figure 2. Principal components plot (PC2 v PC1) with bases formed using genotypes of individuals of African descent included in
Hapmap3 study. ASW: African ancestry in Southwest USA, LWK: Luhya in Webuhe, Kenya, MKK: Maasai in Kinyawa, Kenya, TZ: Tanzanian study
population, YRI: Yoruba in Ibadan, Nigeria.
doi:10.1371/journal.pone.0111464.g002
Figure 3. Summary of the genome-wide association results of
normalized HbF within Tanzanian individuals with SCA. Q–Q
plot of the observed versus the expected P-values from a linear mixed
model for the entire set of 15,153,765 SNPs.
doi:10.1371/journal.pone.0111464.g003
GWAS of HbF in SCA in Tanzania
PLOS ONE | www.plosone.org 3 November 2014 | Volume 9 | Issue 11 | e111464
additive regressions in R (http://www.r-projects.org/) using
threshold-called genotypes after controlling for sex, age, and 10
principal components. Conditional analyses were performed using
MMM with each conditioned variant included as a fixed effect
covariate. We generated quantile-quantile (Q-Q) and Manhattan
plots using R, and regional association plots using LocusZoom
[22].
Results
We performed a genome wide association study for HbF in a
discovery cohort of 1,213 patients (52.6% females) with SCA and a
replication cohort of 321 patients (54.8% females) of African
Caribbean descent or West African descent. Details on age, sex
and HbF levels are presented in Table 1. The genomic control
(lGC) for the analysed SNPs was 1.0156 and a Q–Q plot of the
observed versus expected P-values is shown in Figure 3. The
absence of an early departure of the observed P-values suggests
that our data are not affected by problems with genotyping,
imputation, and uncontrolled sample relatedness or population
stratification. The distribution of association P-values (Manhattan
plot) for HbF level is shown in Figure 4.
As in previous genome wide studies, we have strongly replicated
2 loci that have been associated with HbF: near BCL11A
(rs1427407, Beta =20.30, P = 3.74610253) on chromosome 2
and the HMIP (rs9494145, Beta = 0.23, P= 2.42610210) situated
on chromosome 6. Notably, none of the variants situated at the
HBB and KLF loci could be replicated in our study. We have
detected 8 novel loci with genome wide significance of P,161026
(Table 2). Of these, the top 3 significant SNPs include;
rs28567737 (Beta =20.12, P= 4.2661028) situated on chromo-
some 19, rs10468869 (Beta = 0.09, P= 1.3361027) on chromo-
some 18 and rs62573842 (Beta = 0.11, P= 1.8861027) on
chromosome 9. However, none of the novel loci could be
validated in our replication set (Table 2).
The SNP with the strongest signal (rs1427407, Beta =20.30,
P= 3.74610253) was situated in the second intron of BCL11A.
Our initial analysis highlighted the presence of several SNPs in LD
(R2) with rs1427407 (our top signal). To gain further insight on
this region, we performed a stepwise conditional regression
analysis (Table 3). After conditioning on rs1427407, there was a
significant increase in association at rs6545816 (P = 2.55610215
compared to P=0.58 before conditioning). This finding suggests
an independent BCL11A effect that might be tagged by
rs6545816. A third conditional analysis using the first two
BCL11A variants identified a third candidate variant,
rs58955256 with suggestive significance (P= 1.5261026).
Discussion
GWAS have been previously applied in the identification of
genetic variants that regulate levels of HbF, both in healthy
individuals and those with SCA [5–8,12]. To date, three primary
loci; BCL11A,HMIP andHBB at chromosomes 2, 6 and 11 have
been reported to account for 20%–50% of HbF inter-individual
variation in non-anemic Europeans [13]. However, the contribu-
tion of these loci in African populations has been estimated to be
lower [8]. Our study represents the first GWAS in 1213 SCA
patients from a single site in Africa.
Our findings have confirmed the genetic association of BCL11A
and HMIP in the regulation of HbF. Our work also supports the
likely causality of rs1427407 at the BCL11A locus, as recently
reported [16], as well as the presence of multiple independent risk
variants. The rs1427407 falls within a peak of GATA1 andTAL1
binding and the minor T allele is believed to disrupt a composite
motif bound by GATA1 [16]. Rs6545816 sits 3kb from
rs1427407 while rs58955256 is further upstream of rs1427407
(130 kb). These variants sit near regions with regulative activity
within the BCL11A gene (Figure 5), however, their specific
functions have not yet been reported and should be considered
for further research.
Figure 4. Manhattan plot for normalized HbF association results (-log10P) plotted against the position on each chromosome. The red
horizontal line indicates genome wide suggestive at 561028 and blue line indicates genome wide suggestive at 161025.
doi:10.1371/journal.pone.0111464.g004
Table 1. Characteristics of SCA populations in Tanzania and UK.
Tanzania UK
Number 1,213 321
Gender (% female) 52.6 54.8
Age, Y 11 [IQR: 7.9–16.5] 25 [IQR:19–36]
HbF% 4.6 [IQR: 2.5–7.7] 6 [IQR: 2.9–10.3]
doi:10.1371/journal.pone.0111464.t001
GWAS of HbF in SCA in Tanzania
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Although we validated the HMIP association, the allele
frequency was extremely low (6%) resulting in a much smaller
amount of HbF variance explained by the locus (2.54%) compared
to other populations. It is worth noting that this SNP resides within
block 2 of HMIP, a region where most of the significant SNPs
from other studies are located. The HBB association with HbF
was below the genome wide significance level with most variants
with P values of x1025reason for this could be that HBB variants
are rare in our population, as reflected in allele frequencies (EAF
of less than 5%) reported in our previous study [12] In a study in
Cameroon, the HBB variant (rs7482144) studied was also found
to be rare (MAF=0.07) [23]. With a better sample size such as in
meta-analyses, it may be possible to improve the association signal.
Similarly, the KLF1 association with HbF that has been previously
reported [9] was not detected in this study.
The discovery of additional loci has become increasingly
challenging mostly because the effect size of a new locus is likely
to be lower than that of the 3 primary loci. Our study has
identified 8 suggestive novel SNPs worthy of follow up in larger
studies. One of these, rs28567737 on chromosome 19 (Figure 6),
was genome-wide significant (4.961028), and was in high LD
(0.991) with rs10414361 (P = 1.3161027), a variant directly typed
on the Omni2.5 assay. The lack of validation of the suggestive loci
in the UK cohort may be due to the small sample size or different
ancestry. The latter is likely to be more significant as most of the
UK patients have a Caribbean and West African origin while the
population in our study is from East Africa. In addition, studies of
SCD suggest that there is a considerable heterogeneity in the
genetic and environmental composition of SCD populations
within Africa [23,24] let alone in different continents. Based on
differences in ancestry, it is likely that these populations would
have different sickle haplotypes with the majority of individuals
within the UK cohort carrying the Senegal/Benin haplotype while
most of the Tanzanian patients would carry the Bantu/Central
African Republic (CAR) in. In addition, HbF regulation pathways
may develop differently in different populations [8], hence, allele
frequencies may differ across populations. Such a difference has
been previously observed for HMIP tag SNP (rs9399137) variant
which was found to be less common in the Tanzanian
(MAF=0.01) compared with the UK patients (MAF=0.07)
[12]. In this study we observed lower minor allele frequencies
for the suggestive variants within the replication cohort compared
to the discovery cohort (Table 2). Another difference observed was
high levels of HbF in the UK cohort than those of Tanzanian
patients. It is therefore critical that replication studies are done
with cohorts within the same geographical region as it is likely that
there will be more homogeneity in ancestry. The best replication
population for our study would have been from East Africa,
however, SCA studies with required HbF data and DNA samples
are scarce.
This study highlights the importance of studying disease
relevant phenotypes in large populations from individual sites in
Africa in order to characterize genetic risk with locale-specific
allele frequencies. We believe datasets such as this will form the
foundation of international meta-analyses of SCA and other
diseases prevalent in Africa.
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